Your browser doesn't support javascript.
loading
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
Li, Kai; Liao, Ning; Chen, Bo; Zhang, Guochun; Wang, Yulei; Guo, Liping; Wei, Guangnan; Jia, Minghan; Wen, Lingzhu; Ren, Chongyang; Cao, Li; Mok, Hsiaopei; Li, Cheukfai; Lin, Jiali; Chen, Xiaoqing; Zhang, Zhou; Hou, Ting; Li, Min; Liu, Jing; Balch, Charles M; Liao, Ning.
Afiliação
  • Li K; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Liao N; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Chen B; School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang G; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Wang Y; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Guo L; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Wei G; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Jia M; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Wen L; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Ren C; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Cao L; School of Medicine, South China University of Technology, Guangzhou, China.
  • Mok H; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Li C; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Lin J; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Chen X; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Zhang Z; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Hou T; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Li M; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Liu J; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Balch CM; Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
  • Liao N; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Breast Cancer Res Treat ; 183(2): 321-332, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32638235
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Receptor ErbB-2 / Terapia Neoadjuvante / Povo Asiático / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Receptor ErbB-2 / Terapia Neoadjuvante / Povo Asiático / Mutação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article